COCP
NASDAQ · Pharmaceuticals
Cocrystal Pharma Inc
$1.03
-0.06 (-5.50%)
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+2,610.7% upside
Low Target
$19.61
Average Target
$27.92
High Target
$38.36
Current Price
$1.03
Current
$1.03
$1.03
Target
$27.92
$27.92
$19.61
$27.92 avg
$38.36
Scenario Analysis
Bear Case
$19.61
1,803.9%
Low target
Base Case
$27.92
+2,610.7%
Avg target
Bull Case
$38.36
+3,624.3%
High target
Risk/Reward
2.0x
Favorable
Price in Context
52-Week High
$2.67
-61.4% from high
52-Week Low
$0.86
+19.9% from low
Target vs 52W High
$27.92
+945.7% vs high
Next Earnings Report
Apr 6, 2026 · After Market Close
10d
until earnings
EPS Est: $-0.18
Earnings in 10 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| LLY | Strong Buy | 39 | 77% | $1,330.33 | +45.2% |
| JNJ | Buy | 32 | 59% | $299.55 | +24.8% |
| MRK | Buy | 36 | 67% | $159.27 | +33.4% |
| PFE | Hold | 35 | 40% | $33.90 | +24.3% |
| BMY | Hold | 36 | 42% | $174.50 | +196.1% |
| ZTS | Buy | 25 | 64% | $209.87 | +79.8% |
| RPRX | Strong Buy | 16 | 88% | $36.26 | -22.9% |
| VTRS | Buy | 18 | 67% | $122.82 | +809.8% |